These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4859623)

  • 1. Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
    Cevallos JL; Hagen GA; Maloof F; Chapman EM
    N Engl J Med; 1974 Jan; 290(3):141-3. PubMed ID: 4859623
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
    Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
    N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothyroidism following iodine-131 therapy.
    Hayes MT
    J Nucl Med; 1982 Feb; 23(2):176-9. PubMed ID: 6173470
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
    Gómez N; Gómez JM; Orti A; Gavaldà L; Villabona C; Leyes P; Soler J
    J Nucl Med; 1995 Sep; 36(9):1539-42. PubMed ID: 7658207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy.
    Refetoff S; Demeester-Mirkine N; Ermans AM; DeGroot LJ
    J Nucl Med Allied Sci; 1977; 21(1-2):23-9. PubMed ID: 578811
    [No Abstract]   [Full Text] [Related]  

  • 6. Five years' experience with iodine-125 therapy of Graves' disease.
    Weidinger P; Johnson PM; Werner SC
    Lancet; 1974 Jul; 2(7872):74-7. PubMed ID: 4136737
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lat e results of the radioactive iodine treatments of toxic goiter].
    Kurbatova LI
    Klin Med (Mosk); 1975 May; 52(5):46-50. PubMed ID: 1173451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possible sequelae of the action of radioactive iodine in man].
    Il'in LA; Arkhangel'skaia GV
    Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism].
    Dradi C; Riceputi G; Biagioli R; Riva P
    Minerva Med; 1979 Jan; 70(2):135-41. PubMed ID: 581903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
    Schrub JC; Nouel JP; Brunelle P; Segond G; Courtois H; Poirier A
    Nouv Presse Med; 1976 May; 5(21):1346-8. PubMed ID: 778789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-term course of Graves-Basedow disease treated with I131. Prevalence of transient hypothyroidism].
    Virgili N; Gómez JM; Montaña E; Soler J; Castells M; Roca M
    Rev Clin Esp; 1988 Oct; 183(6):300-3. PubMed ID: 3217548
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism.
    Safa AM; Schumacher OP; Rodriguez-Antunez A
    N Engl J Med; 1975 Jan; 292(4):167-71. PubMed ID: 45842
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk of late hypothyroidism following iodine isotope treatment in Graves-Basedow hyperthyroidism. Statistical study for a 10,000 rads dose and 10-year follow-up].
    Massin JP; George C; Lellouch J; Thomopoulos P; Veber M; Savoie JC
    Pathol Biol (Paris); 1972 Dec; 20(23):965-77. PubMed ID: 4568036
    [No Abstract]   [Full Text] [Related]  

  • 15. Compensated low-dose 131I therapy of Graves' disease.
    Roudebush CP; Hoye KE; DeGroot LJ
    Ann Intern Med; 1977 Oct; 87(4):441-3. PubMed ID: 578665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch; Horst W
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole.
    Clerc J; Izembart M; Dagousset F; Jaïs JP; Heshmati HM; Chevalier A; Léger AF; Barritault L
    J Nucl Med; 1993 Mar; 34(3):387-93. PubMed ID: 8441028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis.
    Khanna CM; Sankar R; Magdum M; Gera A
    J Assoc Physicians India; 1998 Mar; 46(3):268-72. PubMed ID: 11273344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambulatory treatment of hyperthyroidism with radioiodine].
    Konrády A
    Orv Hetil; 2000 Apr; 141(17):938-9; author reply 939-41. PubMed ID: 10827475
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypothyreosis after I-131 therapy of Graves-Basedow disease].
    Fazakas S; Kiss B; Erdei I; Petrányi G
    Orv Hetil; 1975 Oct; 116(43):2523-6. PubMed ID: 1242529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.